Medicare

AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie Inc. (NYSE: ABBV) heads into December 2025 as one of the world’s largest healthcare companies, with new migraine data, fresh oncology approvals, a raised 2025 profit forecast and looming U.S. drug‑pricing reforms all shaping sentiment around the stock. The

1 December 2025

AbbVie (ABBV) Stock Outlook Before the December 1, 2025 Open: Skyrizi’s Canada Win, Medicare Cuts and Fresh Analyst Targets

AbbVie Inc. (NYSE: ABBV) heads into Monday’s December 1, 2025 open sitting near the middle of its recent trading range, with a lot of fresh information for investors to digest from November 28–30. As of the latest close on November

30 November 2025

Healthcare · Investment · Market Analysis · NYSE:ABBV · Pharmaceuticals · Stocks

Novo Nordisk (NVO) Stock Rebounds as Wegovy Upgrade and Medicare Deal Ease Pricing Fears – 26 November 2025

Novo Nordisk A/S stock is staging a sharp rebound today, 26 November 2025, as investors digest a trio of major developments: an FDA filing for a higher-dose version of its blockbuster obesity drug Wegovy, clarity on steep—but largely expected—Medicare price

26 November 2025

Financial Analysis · Healthcare · Investment News · Pharmaceuticals · Stock Market

AbbVie (ABBV) Stock Today, November 26, 2025: Share Price Dip Amid FDA Win, Medicare Drug Price Cuts and Bullish Options Signals

AbbVie Inc. (NYSE: ABBV) is trading lower today, but the big pharma giant remains near multi-year highs as investors digest a powerful mix of good news (a major FDA approval, strong Q3 numbers) and growing policy headwinds from U.S. Medicare

26 November 2025

Financial News · Healthcare Policy · Investment Strategies · NYSE:ABBV · Pharmaceutical Industry · Stock Market

UnitedHealth Group (UNH) Stock Today, November 26, 2025: Price Action, Medicare Shockwaves and What Investors Are Watching

UnitedHealth Group Incorporated (NYSE: UNH) shares traded higher on Wednesday, November 26, 2025, as Wall Street digested fresh headlines on Medicare commissions, tense hospital contract talks and new institutional trading disclosures. In late trading, UNH was changing hands around $330–331,

26 November 2025

Financial News · Healthcare · Investing · Medicare · NYSE:UNH · Stock Market

GSK News Today (26 November 2025): Medicare Slashes Prices on Trelegy, Berenberg Lifts Target, and Buybacks Signal Confidence

GSK plc (LSE/NYSE: GSK) is in the spotlight today as U.S. Medicare unveils steep price cuts on key respiratory drugs, analysts lift their price targets, and regulators publish fresh details on the company’s ongoing share buyback programme. Here’s a complete,

26 November 2025

Company Updates · Healthcare News · Medicare · Pharma · Stock Market

AbbVie (ABBV) Stock Today: Price, Analyst Views, Medicare News and New Biotech Award – November 25, 2025

AbbVie Inc. (NYSE: ABBV) ended Tuesday, November 25, 2025, on a firmer footing, closing at $231.80, up about 1.0% on the day and recovering some of Monday’s pullback. The move came amid a flurry of fresh headlines: U.S. Medicare confirmed

25 November 2025

Analyst Opinions · Biotech News · Investment Insights · Medicare Updates · NYSE:ABBV · Stock Market

Medicare 2026 Premiums Jump Nearly 10%: How Much of Your 2.8% Social Security COLA Will You Actually Keep?

As of today, November 24, 2025, the picture for retirees in 2026 is getting clearer — and more expensive. The Centers for Medicare & Medicaid Services (CMS) has confirmed that standard Medicare Part B premiums will rise nearly 10% next

24 November 2025

Health Insurance · Medicare · Personal Finance · Retirement Planning · Social Security

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UNH Stock Forecast for 2026: Can UnitedHealth Survive the DOJ Storm and Medicare Cuts? (Updated November 15, 2025)

UnitedHealth Group’s UNH stock has become one of the most controversial names in the Dow in 2025. After a brutal sell-off driven by a massive cyberattack, rising medical costs and intensifying federal investigations, the stock is trying to stage a

15 November 2025

Financial Forecasts · Healthcare Industry · Investment Analysis · NYSE:UNH · Stock Market · UnitedHealth Group

Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Lawsuit Outcome and Court Ruling Humana (the second‐largest Medicare Advantage insurer) sued CMS in July after its star rating unexpectedly plunged. The insurer argued that CMS unfairly flagged three interpreter calls as failures (with no callback allowed), causing a 4.5-to-3.5

15 October 2025

Healthcare · Insurance · Legal News · Medicare · NYSE:HUM · Stock Market

Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Stock Performance (Oct 3, 2025) As of midday Oct 3, Humana shares were $272.05, up about +6.01% on the day reuters.com. Yesterday’s close (Oct 2) was $256.62 reuters.com, so HUM has recovered much of last week’s slide. In fact, Oct 1 saw a ~5% drop

3 October 2025

Financial News · Healthcare · Investing · Medicare · NYSE:HUM · Stock Market · Stocks